Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
NEJM 367:625-635, Olesen, J.B.,et al, 2012
Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
AJNR 33:1403-1410, Marder, C.P.,et al, 2012
Antiplatelets vs Anticoagulation for Dissection
Neurol 79:686-689, Kennedy, F.,et al, 2012
Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012
Early Administration of Aspirin in Patients Treated with Alteplase for Acute Ischaemic Stroke: A Randomised Controlled Trial
Lancet 380:731-737, Zinkstok, S.M.,et al, 2012
Interventional Stroke Therapies in the Elderly: Are We Helping?
AJNR 33:638-642, Zeevi,N.,et al, 2012
Update on the Pathophysiology and Management of Idiopathic Intracranial Hypertension
JNNP 83:488-494, Biousse,V.,et al, 2012
Mechanical Thrombectomy in Severe Acute Stroke: Preliminary Results of the Solitaire Stent
JNNP 83:117-118, Mpotsaris,A.,et al, 2012
Progress for Stroke Prevention with Atrial Fibrillation
Stroke 43:1179-1185, Katsnelson,M.,et al, 2012
Dual or Mono Antiplatelet Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Stroke 43:1058-1066, Geeganage,C.M.,et al, 2012
Anticoagulation for Cerebral Venous Sinus Thrombosis
Stroke 43:e41-e42, Coutinho,J.M.,et al, 2012
A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke
NEJM 366:1099-1107, Parsons,M.,et al, 2012
Requirements for Emergent Neurosurgical Procedures among Patients Undergoing Neuroendovascular Procedures in Contemporary Practice
AJNR 33:465-468, Khatri,R.,et al, 2012
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Infarct Volume is a Pivotal Biomarker After Inter-Arterial Stroke Therapy
Stroke 43:1323-1330, Yoo,A.J.,et al, 2012
All Patients Should Be Admitted to the Hospital After a Transient Ischemic Attack
Stroke 43:1446-1447,1450, Cucchiara, B.L. & Kasner,S.E., 2012
Neurointerventional Procedural Volume per Hospital in United States
Stroke 43:1309-1314, Grigoryan, M.,et al, 2012
Not all Patients Should Be Admitted to the Hospital for Observation After a Transient Ischemic Attack
Stroke 43:1448-1449,1450, Amarenco,P., 2012
Predictors of Rapid Brain Imaging in Acute Stroke
Stroke 43:1279-1284, Kelly,A.G.,et al, 2012
Bridging Therapy in Acute Ischemic Stroke
Stroke 43:1302-1308, Mazighi,M.,et al, 2012
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
Statins and Intracerebral Hemorrhage
Arch Neurol 69:39-45,13, Hackam,D.G,et al, 2012
New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012
Self-Monitoring of Oral Anticoagulation: Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 379:322-34, Heneghan,C., 2012
Emergency Department Adherence to American Heart Association Guidelines for Blood Pressure Management in Acute Ischemic Stroke
Stroke 43:557-559, McDonough,E.,et al, 2012
Low-Molecular-Weight Heparin Versus Aspirin for Acute Ischemic Stroke with Large Artery Occlusive Disease
Stroke 43:346-349,293, Wang,Q.S,et al, 2012
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012
How Often Are Patients With Ischemic Stroke Eligible for Decompressive Hemicraniectomy?
Stroke 43:550-552, Rahme,R.,et al, 2012
Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012
Clinical Reasoning: A 33-year-old Woman with Severe Postpartum Occipital Headaches
Neurol 78:366-369, Maalouf,N. and Harik,S.I., 2012
Insulin for Glycemic Control in Acute Ischemic Stroke
Stroke 43:e29, Bellolio,M.F.,et al, 2012
The Argatroban and Tissue-Type Plasminogen Activator Stroke Study
Stroke 43:770-775,623, Barreto,A.D.,et al, 2012
Does Helicopter Emergency Medical Service Transfer Offer Benefit to Patients with Stroke?
Stroke 43:878-880, Olson,M.D. and Rabinstein,A.A., 2012
Asymmetric Pattern of Cerebrovascular Lesions in Patients after Left Ventricular Assist Device Implantation
Stroke 43:872-874, Kato,T.S.,et al, 2012
Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012
Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012
The Types of Neurological Deficits Might Not Justify Withholding Treatment in Patients with Low Total National Institutes of Health Stroke Scale Scores
Stroke 43:782-786,625, Leira,E.C.,et al, 2012
Variable Presentations of Postpartum Angiopathy
Stroke 43:670-676, Fugate,J.E.,et al, 2012
Insufficient Platelet Inhibition is Related to Silent Embolic Cerebral Infarctions After Coronary Angiography
Stroke 43:727-732, Kim,B.J.,et al, 2012
Topographic Location of Acute Pontine Infarction is Associated with the Development of Progressive Motor Deficits
Stroke 43:708-713, Oh,S.,et al, 2012
Selecting Stroke Patients for Intra-Arterial Therapy
Neurol 78:755-761, Balucani,C. and Grotta,J.C., 2012
Middle Cerebral Artery Intraplaque Hemorrhage: Prevalence and Clinical Relevance
Ann Neurol 71:195-198, Xu,W.H.,et al, 2012
Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012
Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012
Does Intracranial Venous Thrombosis Cause Subdural Hemorrhage in the Pediatric Population?
AJNR 33:1281-1284, McLean, L.A.,et al, 2012
Do We Have to Stop Anticoagulant and Platelet-Inhibitor Treatments During Proctological Surgery?
Colorectal Dis 14:16-20, Pigot, F.,et al, 2012
Cerebral Sinus Thrombosis in Scleroderma
Acta Med Iran 50:288-291, Fard, M.P. & Magham, S.K., 2012
Dissecting Aneurysm of the Anterior Temporal Artery - Case Report -
Neurol Med Chir (Tokyo) 51:777-780, Umeoka,K., et al, 2011
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011
Warfarin-Related Intraventricular Hemorrhage
Neurol 77:1840-1846, Biffi, A.,et al, 2011